HIV in the United States at the turn of the century: An epidemic in transition

American Journal of Public Health

Volumn 91, Issue 7, 2001, Pages 1060-1068

  Karon, J M ^a   Fleming, P L ^a   Steketee, R W ^a   De Cock, K M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; SEROPREVALENCE; UNITED STATES;

EID: 0034971814     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.91.7.1060     Document Type: Article

References (51)

1. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome
2. Trends in perinatal transmission of HIV/AIDS in the United States
3. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
4. Using surveillance data to monitor trends in the AIDS epidemic
5. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
6. Trends in HIV incidence among young adults in the United States
7. AIDS incubation in 1891 HIV seroconverters from different exposure groups
8. HIV infection in disadvantaged out-of-school youth: Prevalence for US Job Corps entrants, 1990 through 1996
9. HIV prevalence and associated risks in young men who have sex with men
10. Trends in HIV prevalence among childbearing women in the United States, 1989-1994
11. High HIV seroincidence in nonwhite bisexual men making repeat visits to a New York City sexually transmitted disease clinic, 1994-1995: Results of a blinded longitudinal survey
12. The feasibility of HIV-1 vaccine efficacy trials among gay-bisexual men in New York City: Project ACHIEVE
13. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate
14. Feasibility of conducting HIV-1 vaccine trials in the United States: Recruitment, retention and HIV-1 seroincidence from the HIV Network for Prevention Trials (HIVNET) Vaccine Preparedness Study (VPS)
15. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM)
16. HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996
17. Detection of early HIV infection and estimation of incidence using a sensitive/less sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco
18. Differences in temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: Application of the serologic testing algorithm for recent HIV seroconversion (STARHS)
19. HIV incidence among young men who have sex with men - Seven US cities, 1994-2000
20. HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic
21. Temporal trends, demographic and behavioral risk factors for HIV incidence among injection drug users in Baltimore, 1988-1997
22. Lower risk of HIV infection with continued regular participation in needle exchange program
23. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
24. HIV incidence among injection drug users enrolled in a Los Angeles methadone program
25. Incidence of HIV among injection drug users entering drug treatment programs in four US cities
26. Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993
27. The incidence of HIV infection among men in the United States Army Reserve Components, 1985-1991
28. HIV infection among women in the Army Reserve Components
29. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: A comparison of apheresis and whole-blood donors
30. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
31. Demographic correlates of HIV incidence among US blood donors
32. Epidemiology of HIV-1 seroconversion among young adults in the US Army, 1985-1996: Current trends in an evolving epidemic
33. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of anti-retroviral agents in HIV-infected adults and adolescents
34. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
35. Effects of anti-retroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
36. Declines in AIDS incidence and deaths in the USA: A signal change in the epidemic
37. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
38. Scope of the AIDS epidemic in the United States
39. HIV testing patterns: Where, why, and when were persons with AIDS tested for HIV?
40. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
41. Predictors for not currently receiving protease inhibitor therapy: Results from a multisite interview project
42. Access of vulnerable groups to anti-retroviral therapy among persons in care for HIV disease in the United States
43. Adherence to currently prescribed anti-retroviral therapies: Results from a multisite interview project
44. Tracking the HIV epidemic: Current issues, future challenges
45. Geographical AIDS rates and socio-demographic variables in the Newark, New Jersey metropolitan area
46. Income and AIDS rates in Los Angeles County
47. Socioeconomic differences among people with AIDS: Results from a multistate surveillance project
48. Increases in unsafe sex and rectal gonorrhea among men who have sex with men - San Francisco, California, 1994-1997
49. Are at-risk populations less concerned about HIV infection in the HAART era?